Editorial comment.
Konety
Badrinath R
BR
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D000077143:Docetaxel; D006801:Humans; D043823:Taxoids / Q000008:administration & dosage*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel